Event Abstract

Back to Event

Pre- and postsynaptic changes at cortico-striatal synapses in xCT deficient mice

Eduard Bentea1*, Cynthia Moore2, Madeline J. Churchill2, Agnes Villers3, Rebecca L. Hood4, Lauren Deneyer1, Lise Verbruggen1, Giulia Albertini5, Hideyo Sato6, Laurence Ris3, Charles K. Meshul2, 4 and Ann Massie1
  • 1 Vrije Universiteit Brussel, Department of Pharmaceutical Biotechnology and Molecular Biology, Belgium
  • 2 Veterans Affairs Medical Center, Research Services, United States
  • 3 University of Mons, Department of Neurosciences, Belgium
  • 4 Oregon Health and Science University, Department of Behavioral Neuroscience, United States
  • 5 Vrije Universiteit Brussel, Department of Pharmaceutical Chemistry and Drug Analysis, Belgium
  • 6 Niigata University, Department of Medical Technology, Japan

System xc- is a plasma membrane amino acid antiporter, of mainly glial origin, that couples the import of cystine with the export of glutamate. System xc- (specific subunit xCT) contributes substantially to ambient extracellular glutamate levels in various regions of the brain, including the striatum and hippocampus. Despite the fact that system xc- is highly expressed in the brain and is a proposed therapeutic target for various neurological disorders, including Parkinson’s disease, Alzheimer’s disease, multiple sclerosis and epilepsy, its function under physiological conditions in the central nervous system remains poorly understood. By acting as a source of glial extrasynaptic glutamate, system xc- might modulate synaptic transmission as a mechanism of neuro-glial communication. Previous electrophysiological findings indicate that system xc- delivered glutamate can inhibit excitatory synaptic neurotransmission in the cortico-accumbens pathway (Moran et al. J Neurosci. 2005; 25:6389-93) and at hippocampal CA3-CA1 synapses (Williams et al. J Neurosci. 2014; 34:16093-102). In order to gain further insight into the proposed function of system xc- as modulator of synaptic transmission, we carried out single section electron microscopy analyses of cortico-striatal excitatory synapses in adult xCT knockout (xCT-/-) and xCT wildtype (xCT+/+) mice. Our preliminary findings reveal depletion of glutamate immunogold labeling from presynaptic terminals of xCT-/- mice, an increase in the head diameter and area of spines contacted by asymmetric synapses, enlargement of the postsynaptic density and an increased occurrence of spinules, post-synaptic elements of high efficacy. These synaptic changes occurred in the absence of differences in the total density of cortico-striatal synapses or dendritic spines in the dorsolateral striatum of xCT-/- vs. xCT+/+ mice. Our results suggest the involvement of both presynaptic and postsynaptic forms of synaptic strength regulation via system xc-. Whether the structural changes we observed indicate a global increase in cortico-striatal transmission in xCT-/- mice, or conversely, represent forms of synaptic compensation, is being addressed by electrophysiological measures of excitatory post-synaptic currents in xCT-/- mice after cortical stimulation. Together, our findings shed new light on the re-organization of the glutamatergic system after genetic deletion of system xc-, and confirm the involvement of this antiporter in the control of synaptic strength in vivo.

Keywords: XCT, Glutamate, corticostriatal pathway, Electron microscopy, Synaptic Transmission

Conference: 12th National Congress of the Belgian Society for Neuroscience, Gent, Belgium, 22 May - 22 May, 2017.

Presentation Type: Oral Presentation

Topic: Neural Excitability, Synapses, and Glia: Cellular Mechanisms

Citation: Bentea E, Moore C, Churchill MJ, Villers A, Hood RL, Deneyer L, Verbruggen L, Albertini G, Sato H, Ris L, Meshul CK and Massie A (2019). Pre- and postsynaptic changes at cortico-striatal synapses in xCT deficient mice. Front. Neurosci. Conference Abstract: 12th National Congress of the Belgian Society for Neuroscience. doi: 10.3389/conf.fnins.2017.94.00050

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 24 Apr 2017; Published Online: 25 Jan 2019.

* Correspondence: PhD. Eduard Bentea, Vrije Universiteit Brussel, Department of Pharmaceutical Biotechnology and Molecular Biology, Brussels, Belgium, ebentea@yahoo.com